We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) (CHALLAH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00711035
Recruitment Status : Completed
First Posted : July 8, 2008
Last Update Posted : April 26, 2016
Texas Children's Hospital
The Methodist Hospital System
Brigham and Women's Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
National Marrow Donor Program
The EMMES Corporation
Duke University
Beth Israel Deaconess Medical Center
Children's Hospital Los Angeles
National Heart, Lung, and Blood Institute (NHLBI)
Boston Children’s Hospital
University of Miami
Hackensack University Medical Center
University of California, Los Angeles
Information provided by (Responsible Party):
Helen Heslop, Baylor College of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2012
  Study Completion Date : August 2013
  Certification or Request for Extension to Delay Results Submission: March 3, 2014